For the first time in history, a trial of a new cancer drug experiences 100 percent remission. Every new drug developed by scientists is required to go through numerous tests before FDA approval. It is rare to see a 50 percent success rate during early trials. A drug to cure colorectal cancer known as “dostarlimab” […]
The post Trial of a New Cancer Drug Experiences 100% Remission appeared first on Guardian Liberty Voice.